Lv4
488 积分 2024-04-30 加入
Decade-long persistence of CD19 CAR T cells in B cell lymphomas
5小时前
待确认
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
22天前
已完结
T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Breathing new life into T-cell receptor-engineered T-cell therapy in solid tumors: enhancing strategies to expand the universality of precision therapy
1个月前
已关闭
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
3个月前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
3个月前
已完结
Correspondence on: ‘CD19-CAR T-cell therapy induces deep tissue depletion of B cells’ by Tur et al
3个月前
已关闭
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
3个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
